Cargando…
Omega-3 Fatty Acid Based Nanolipid Formulation of Atorvastatin for Treating Hyperlipidemia
Purpose: In the current study, attempts have been made to formulate an omega-3 fatty acid based nanostructured lipid carriers of atorvastatin (AT), for treating hyperlipidemia; and to evaluate their antihyperlipidemic activity using in vitro and in vivo studies. Methods: Omega-3 fatty acid based AT-...
Autores principales: | Sreedhar, Revathy, Kumar, Vrinda Sasi, Bhaskaran Pillai, Anil Kumar, Mangalathillam, Sabitha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664121/ https://www.ncbi.nlm.nih.gov/pubmed/31380253 http://dx.doi.org/10.15171/apb.2019.031 |
Ejemplares similares
-
Formulation and delivery of itraconazole to the brain using a nanolipid carrier system
por: Lim, Wei Meng, et al.
Publicado: (2014) -
Development and Optimization of Nanolipid-Based Formulation of Diclofenac Sodium: In Vitro Characterization and Preclinical Evaluation
por: Zafar, Ameeduzzafar, et al.
Publicado: (2022) -
Nose to Brain Delivery of Phenytoin Sodium Loaded Nano Lipid Carriers: Formulation, Drug Release, Permeation and In Vivo Pharmacokinetic Studies
por: Nair, Sreeja C., et al.
Publicado: (2021) -
Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers
por: Colombo, Eleonora, et al.
Publicado: (2019) -
Pharmacokinetic Interaction between Atorvastatin and Omega-3 Fatty Acid in Healthy Volunteers
por: Kim, Jae Hoon, et al.
Publicado: (2022)